384 related articles for article (PubMed ID: 21183840)
1. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
Kirkwood CD; Boniface K; Barnes GL; Bishop RF
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S48-53. PubMed ID: 21183840
[TBL] [Abstract][Full Text] [Related]
2. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.
Hull JJ; Teel EN; Kerin TK; Freeman MM; Esona MD; Gentsch JR; Cortese MM; Parashar UD; Glass RI; Bowen MD;
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S42-7. PubMed ID: 21183839
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.
Roczo-Farkas S; Kirkwood CD; Cowley D; Barnes GL; Bishop RF; Bogdanovic-Sakran N; Boniface K; Donato CM; Bines JE
J Infect Dis; 2018 Jul; 218(4):546-554. PubMed ID: 29790933
[TBL] [Abstract][Full Text] [Related]
4. Characterization of G2P[4] rotavirus strains associated with increased detection in Australian states using the RotaTeq® vaccine during the 2010-2011 surveillance period.
Donato CM; Zhang ZA; Donker NC; Kirkwood CD
Infect Genet Evol; 2014 Dec; 28():398-412. PubMed ID: 24861815
[TBL] [Abstract][Full Text] [Related]
5. Australian Rotavirus Surveillance Program annual report, 2013.
Kirkwood CD; Roczo-Farkas S;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E334-42. PubMed ID: 25631596
[TBL] [Abstract][Full Text] [Related]
6. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
[TBL] [Abstract][Full Text] [Related]
7. Rotarix®: vaccine performance 6 years postlicensure.
O'Ryan M; Lucero Y; Linhares AC
Expert Rev Vaccines; 2011 Dec; 10(12):1645-59. PubMed ID: 22085167
[TBL] [Abstract][Full Text] [Related]
8. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.
Carvalho-Costa FA; Volotão Ede M; de Assis RM; Fialho AM; de Andrade Jda S; Rocha LN; Tort LF; da Silva MF; Gómez MM; de Souza PM; Leite JP
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S35-41. PubMed ID: 21048523
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus-associated infantile diarrhea in Uberaba, Minas Gerais, on the wake of the Brazilian vaccination program.
Domingues AL; Morais AT; Cruz RL; Moreira LP; Gouvêa VS
J Clin Virol; 2008 Nov; 43(3):298-301. PubMed ID: 18775667
[TBL] [Abstract][Full Text] [Related]
10. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
[TBL] [Abstract][Full Text] [Related]
11. Distribution of rotavirus G and P genotypes approximately two years following the introduction of rotavirus vaccines in South Korea.
Shim JO; Thai Than V; Ryoo E; Lim I; Yoon Y; Kim K; Chung SI; Kim W
J Med Virol; 2013 Jul; 85(7):1307-12. PubMed ID: 23595867
[TBL] [Abstract][Full Text] [Related]
12. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
13. Australian Rotavirus Surveillance Program: Annual Report, 2018.
Roczo-Farkas S; Bines JE;
Commun Dis Intell (2018); 2021 Jan; 45():. PubMed ID: 33573534
[TBL] [Abstract][Full Text] [Related]
14. Co-dominance of G1 and emerging G3 rotaviruses in Hong Kong: a three-year surveillance in three major hospitals.
Mitui MT; Chan PK; Nelson EA; Leung TF; Nishizono A; Ahmed K
J Clin Virol; 2011 Apr; 50(4):325-33. PubMed ID: 21330195
[TBL] [Abstract][Full Text] [Related]
15. Australian Rotavirus Surveillance Program: Annual Report, 2016.
Roczo-Farkas S; Kirkwood CD; Bines JE;
Commun Dis Intell Q Rep; 2017 Dec; 41(4):E455-E471. PubMed ID: 29864391
[TBL] [Abstract][Full Text] [Related]
16. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
Mukhopadhya I; Murdoch H; Berry S; Hunt A; Iturriza-Gomara M; Smith-Palmer A; Cameron JC; Hold GL
Vaccine; 2017 Jan; 35(1):156-163. PubMed ID: 27876201
[TBL] [Abstract][Full Text] [Related]
17. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.
Donato CM; Ch'ng LS; Boniface KF; Crawford NW; Buttery JP; Lyon M; Bishop RF; Kirkwood CD
J Infect Dis; 2012 Aug; 206(3):377-83. PubMed ID: 22615314
[TBL] [Abstract][Full Text] [Related]
18. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?
Matthijnssens J; Nakagomi O; Kirkwood CD; Ciarlet M; Desselberger U; Van Ranst M
Expert Rev Vaccines; 2012 Nov; 11(11):1347-54. PubMed ID: 23249234
[TBL] [Abstract][Full Text] [Related]
19. Australian Rotavirus Surveillance Program: Annual Report, 2019.
Thomas S; Donato CM; Roczo-Farkas S; Hua J; Bines JE;
Commun Dis Intell (2018); 2021 Jan; 45():. PubMed ID: 33573535
[TBL] [Abstract][Full Text] [Related]
20. Australian Rotavirus Surveillance Program annual report, 2010/11.
Kirkwood CD; Roczo S; Boniface K; Bishop RF; Barnes GL;
Commun Dis Intell Q Rep; 2011 Dec; 35(4):281-7. PubMed ID: 22624488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
